Peter Attia· MD
we personalize care you know if someone has a four we're going to tell them to do certain things someone doesn't have a four we're going to do other things for them because their other things are preferentially effective
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
we personalize care you know if someone has a four we're going to tell them to do certain things someone doesn't have a four we're going to do other things for them because their other things are preferentially effective
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
i believe the future of alzheimer's disease is based in precision medicine using these types of genetic underpinnings understanding all the individual genes that impact a person's risk figuring out what they are figuring out what their biological function is figuring out why it puts a person down the path towards alzheimer's and then telling that person to do a b c x y and z to get them off the path towards alzheimer's that's the future of alzheimer's